Clinical Trial Update: B-type Natriuretic Peptide for the Management of Weaning [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating B-type natriuretic peptide for managing weaning in patients with respiratory insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Insufficiency

Drugs mentioned

• B-type natriuretic peptide (B-type natriuretic peptide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Respiratory Insufficiency | Phase 3 | Status: COMPLETED